ML 18
ML18 is Bombesin receptor subtype 3 (BRS-3) antagonist (IC50 = 4.8 μM) . ML-18 inhibits lung cancer growth. ML-18 inhibited the proliferation of lung cancer cells. ML-18 is a nonpeptide BRS-3 antagonist that should serve as a template to improve potency and selectivity.
Product Specifications
CAS Number
1422269-30-4
Product Name Alternative
ML-18 | ML 18 | ML18
Purity
>98% (HPLC)
Solubility
DMSO : ≥ 100 mg/mL; 175.55 mM
Smiles
COc1ccc (cc1) C1 (CCCCC1) CNC (=O) [C@H] (Cc1c[nH]c2ccccc12) NC (=O) Nc1ccc (cc1) [N+] (=O) [O-]
Molecular Formula
C32H35N5O5
Molecular Weight
569.65
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
(S) -3- (1H-indol-3-yl) -N- ((1- (4-methoxyphenyl) cyclohexyl) methyl) -2- (3- (4-nitrophenyl) ureido) propanamide
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K0158103 1.0 µg DNA
ATXN3L sgRNA CRISPR Lentivector (Human) (Target 2)
Sign In for Pricing
View Details bs-11892R-BF405 100 µL
NAV2 Polyclonal Antibody, AbBy Fluor™ 405 Conjugated
Sign In for Pricing
View Details